Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectally Administered Indomethacin to Prevent Post-ESWL-pancreatitis
NCT02797067Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- May 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of indomethacin in pancreatitis (2 arms), sponsored by Changhai Hospital. Primary endpoint: Incidence of Post-ESWL Pancreatitis at 1 month. Started May 2016; status: completed.
02
Drugs
indomethacin
03
Conditions
pancreatitis
Beyond the preview
Go deeper on NCT02797067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02797067.